Request Information

Premier Perspectives

The blog for insider insights in clinical development

Data Management & Biostatistics

Real-World Data and Real-World Evidence: What Is Their Value as a Synthetic Control Arm?

By

May 26, 2020

Featured Posts

Learn more about the latest events and updates.

COVID-19

Leveraging Emergency Use Authorizations to Bring COVID-19 Products to Market

By

May 7, 2020

COVID-19

PREMIER VOICES #11: Statistical Considerations in the Wake of COVID-19

By

April 30, 2020

Premier Voices Podcast

Conversations with Premier's subject matter experts
Premier Voices #1: Rare Oncology w/ Colin Hayward & Peter Larson

Premier Voices #1

Rare Oncology w/ Colin Hayward & Peter Larson
Listen Now
Premier Voices #2: Registry Studies & Natural Histories in Rare Disease Trials w/ Angi Robinson & Juliet Moritz

Premier Voices #2

Registry Studies & Natural Histories in Rare Disease Trials w/ Angi Robinson & Juliet Moritz
Listen Now
Premier Voices #3: The Placebo Problem Part 1 With Scott Millard

Premier Voices #3

The Placebo Problem Part 1 With Scott Millard
Listen Now
Premier Voices #4: The Placebo Problem Part 2 With Michael Kuss

Premier Voices #4

The Placebo Problem Part 2 With Michael Kuss
Listen Now
Premier Voices #5: Operationalizing the New MDR With Janet Kube (Part 1)

Premier Voices #5

Operationalizing the New MDR With Janet Kube (Part 1)
Listen Now
Premier Voices #6: Operationalizing the New MDR With Janet Kube (Part 2)

Premier Voices #6

Operationalizing the New MDR With Janet Kube (Part 2)
Listen Now
Premier Voices #7: Rare Disease Advocacy & International Ataxia Day w/ Alan Thomas (Ataxia & Me)

Premier Voices #7

Rare Disease Advocacy & International Ataxia Day w/ Alan Thomas (Ataxia & Me)
Listen Now
Premier Voices #8: Engaging Patients in Clinical Trials w/ Alan Thomas & Juliet Moritz

Premier Voices #8

Engaging Patients in Clinical Trials w/ Alan Thomas & Juliet Moritz
Listen Now
PREMIER VOICES #9: COVID-19 Update – What Sponsors Need to Know About the New FDA Guidance

PREMIER VOICES #9

COVID-19 Update – What Sponsors Need to Know About the New FDA Guidance
Listen Now
PREMIER VOICES #10: COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster

PREMIER VOICES #10

COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster
Listen Now

Recent Posts

Learn more about the latest events and updates.

COVID-19

Data Driven: How Electronic Patient-Reported Outcomes (ePROs) Provide a Vital Opportunity to Capture Key Data Beyond the COVID-19 Crisis

By

April 30, 2020

COVID-19

PREMIER VOICES #10: COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster

By

April 7, 2020

COVID-19

COVID-19 & Clinical Trials: Direct-to-Patient Model Keeps Research Moving and Patients Safe

By

April 7, 2020

COVID-19

PREMIER VOICES #9: COVID-19 Update – What Sponsors Need to Know About the New FDA Guidance

By

March 31, 2020

COVID-19

Statistical Considerations for FDA COVID-19 Guidance

By

March 27, 2020

COVID-19

What Is FDA’s Emergency Use Authorization (EUA) and How Can It Help Develop Therapies Faster?

By

March 20, 2020